PANOVA-3 met its primary endpoint with a statistically significant improvement in overall survival for patients with unresectable, locally advanced pancreatic adenocarcinoma treated in the first line with TTFields concomitant with gemcitabine and nab-paclitaxel. Stay up to date on our latest news and information by following Novocure on LinkedIn and Twitter. William Doyle, our Executive Chairman, will take part in a fireside chat at p. EST, as well as one-on-one meetings with investors. This WorldLungCancerDay, we thank the doctors, nurses, caregivers, patient organizations and all who support patients facing this difficult disease.
Today marks the 6th annual GBMDay, when patients, caregivers, and advocates come together to support those living with glioblastoma, remember those we have lost, and reaffirm our commitment to developing innovative treatments and, ultimately, a cure for this disease.
This link will navigate you to an external website outside of Novocure. We are a global oncology company striving to extend survival in some of the most aggressive forms of cancer. Learn more about our company and our mission through stories about patients, our colleagues, our collaborators and our culture.
What does time well spent mean? Novocure joins New Hampshire Life Sciences. Family, music, rocks, fish β Doc Sinclair is a man of many passions.
As he faces brain cancer, he strives to maintain an active, full life. Decades of hiking and rock climbing taught Janice Armbrust how to handle the greatest uphill battle of her life: one day β one step β at a time.
